CYBEROPTICS CORP (CYBE)

US2325171021 - Common Stock

54  0 (0%)

After market: 53.99 -0.01 (-0.02%)

Fundamental Rating

4

CYBE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. No worries on liquidiy or solvency for CYBE as it has an excellent financial health rating, but there are worries on the profitability. CYBE shows excellent growth, but is valued quite expensive already.



2

1. Profitability

1.1 Basic Checks

CYBE had positive earnings in the past year.
CYBE had a positive operating cash flow in the past year.
In the past 5 years CYBE has always been profitable.
CYBE had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 15.04%
ROE 18.59%
ROIC 17.86%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CYBE's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of CYBE has grown nicely.
Industry RankSector Rank
OM 17.6%
PM (TTM) 15.92%
GM N/A
OM growth 3Y43.85%
OM growth 5Y10.73%
PM growth 3Y46.48%
PM growth 5Y-4.66%
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CYBE is creating some value.
The number of shares outstanding for CYBE has been increased compared to 1 year ago.
There is no outstanding debt for CYBE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CYBE has an Altman-Z score of 14.55. This indicates that CYBE is financially healthy and has little risk of bankruptcy at the moment.
CYBE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 14.55
ROIC/WACC1.57
WACC11.35%

2.3 Liquidity

A Current Ratio of 4.45 indicates that CYBE has no problem at all paying its short term obligations.
CYBE has a Quick Ratio of 2.83. This indicates that CYBE is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 4.45
Quick Ratio 2.83

7

3. Growth

3.1 Past

CYBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 104.81%, which is quite impressive.
The Earnings Per Share has been growing slightly by 0.63% on average over the past years.
CYBE shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.08%.
CYBE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.97% yearly.
EPS 1Y (TTM)104.81%
EPS 3Y62.71%
EPS 5Y0.63%
EPS growth Q2Q41.46%
Revenue 1Y (TTM)26.08%
Revenue growth 3Y12.75%
Revenue growth 5Y6.97%
Revenue growth Q2Q9.38%

3.2 Future

CYBE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.37% yearly.
CYBE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.27% yearly.
EPS Next Y21.43%
EPS Next 2Y21.71%
EPS Next 3Y23.07%
EPS Next 5Y24.37%
Revenue Next Year14.47%
Revenue Next 2Y12.8%
Revenue Next 3Y10.34%
Revenue Next 5Y8.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.35, CYBE can be considered very expensive at the moment.
CYBE's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.55.
CYBE is valuated rather expensively with a Price/Forward Earnings ratio of 21.70.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.92, CYBE is valued at the same level.
Industry RankSector Rank
PE 25.35
Fwd PE 21.7

4.2 Price Multiples

Industry RankSector Rank
P/FCF 72.18
EV/EBITDA 18.73

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as CYBE's earnings are expected to grow with 23.07% in the coming years.
PEG (NY)1.18
PEG (5Y)40.42
EPS Next 2Y21.71%
EPS Next 3Y23.07%

0

5. Dividend

5.1 Amount

CYBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CYBEROPTICS CORP

NASDAQ:CYBE (11/3/2022, 8:24:29 PM)

After market: 53.99 -0.01 (-0.02%)

54

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap401.02M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 25.35
Fwd PE 21.7
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.18
PEG (5Y)40.42
Profitability
Industry RankSector Rank
ROA 15.04%
ROE 18.59%
ROCE
ROIC
ROICexc
ROICexgc
OM 17.6%
PM (TTM) 15.92%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.45
Quick Ratio 2.83
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)104.81%
EPS 3Y62.71%
EPS 5Y
EPS growth Q2Q
EPS Next Y21.43%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.08%
Revenue growth 3Y12.75%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y